Table of Contents
Introduction: Peptide vs Coenzyme Neuroprotection
Semax and NAD+ (nicotinamide adenine dinucleotide) represent two fundamentally different molecular approaches to brain health research. Semax is a synthetic peptide that directly upregulates neurotrophic factors like BDNF to support synaptic plasticity and neuronal survival. NAD+ is a universal coenzyme that fuels mitochondrial energy production, activates sirtuins (longevity-associated deacetylases), and supports DNA repair enzymes.
They address different aspects of neurodegeneration: Semax targets neurotrophic signaling (the brain’s growth and plasticity system), while NAD+ targets cellular energy and maintenance (the neuron’s power supply and repair machinery).
Semax: BDNF-Driven Cognitive Enhancement
Semax is a synthetic analog of ACTH(4-10) approved in Russia for stroke recovery and cognitive enhancement. Its primary neuroprotective mechanism is BDNF upregulation:
- BDNF increase: Upregulates brain-derived neurotrophic factor mRNA and protein in hippocampus and cortex
- Synaptic plasticity: Enhanced LTP (long-term potentiation) — the molecular basis of learning
- Dopamine/serotonin modulation: Fine-tunes monoamine neurotransmission
- Anti-ischemic: Protects neurons during oxygen deprivation (stroke models)
- Gene expression: Alters 100+ brain-relevant genes
- Intranasal delivery: Bypasses BBB through nasal mucosa
NAD+: Mitochondrial and Sirtuin-Mediated Neuroprotection
NAD+ is an essential coenzyme found in every living cell, serving as an electron carrier in metabolic reactions and a substrate for critical enzymes. Brain NAD+ levels decline ~50% with aging, contributing to neuronal energy failure and susceptibility to damage.
- Mitochondrial function: Required for oxidative phosphorylation — neurons’ primary ATP source
- Sirtuin activation: Substrate for SIRT1, SIRT3 — deacetylases that promote neuronal survival, reduce inflammation, and enhance mitochondrial biogenesis
- PARP support: Fuels poly(ADP-ribose) polymerase for DNA repair after oxidative damage
- Neuroinflammation: Sirtuin-mediated reduction of NF-?B inflammatory signaling
- Precursors: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are commonly used to boost NAD+ levels
Mechanism Comparison
| Feature | Semax | NAD+ |
|---|---|---|
| Class | Synthetic peptide (7 amino acids) | Coenzyme (dinucleotide) |
| Primary Target | BDNF / neurotrophic signaling | Mitochondria / sirtuins / DNA repair |
| Cognitive Effects | Direct (BDNF ? LTP ? learning/memory) | Indirect (energy ? neuronal function) |
| Anti-Aging | Brain-specific neuroprotection | Systemic (every cell uses NAD+) |
| Energy Metabolism | Not a primary mechanism | Primary mechanism |
| Administration | Intranasal (brain-targeted) | IV, oral precursors (NMN, NR) |
| Regulatory Status | Approved in Russia (prescription) | GRAS (supplement precursors available) |
Neuroprotection Evidence
Semax: Cognitive and Stroke Recovery
Semax has demonstrated cognitive enhancement in animal learning tasks and clinical improvement in stroke patients. Its BDNF upregulation is particularly relevant because BDNF decline is implicated in depression, Alzheimer’s disease, and age-related cognitive decline. Semax-treated animals show enhanced hippocampal BDNF levels and improved performance in spatial memory tasks.
NAD+: Metabolic Neuroprotection
NAD+ depletion is now recognized as a hallmark of brain aging. Restoring NAD+ through precursors (NMN, NR) has shown neuroprotective effects in models of Alzheimer’s, Parkinson’s, and ischemic stroke. The mechanism is fundamentally different from Semax — NAD+ prevents neurons from dying of energy failure and accumulated DNA damage, rather than enhancing their signaling capacity.
Complementary Mechanisms
Semax and NAD+ address non-overlapping aspects of neurodegeneration. A neuron needs both: sufficient neurotrophic support (BDNF — Semax) AND adequate energy and repair capacity (NAD+). Their combination could theoretically provide more comprehensive neuroprotection than either alone, though direct combination studies are lacking.
Choosing the Right Compound
Choose Semax when:
- Cognitive enhancement (learning, memory, attention) is the primary endpoint
- BDNF and neurotrophic factor biology is the research question
- Stroke or cerebral ischemia models are being used
- A peptide with clinical approval precedent is needed
- Brain-targeted intranasal delivery is preferred
Choose NAD+ when:
- Mitochondrial dysfunction is the primary research target
- Sirtuin biology and epigenetic regulation are endpoints
- Systemic aging and metabolic decline are being studied (not brain-specific)
- DNA repair capacity in aging neurons is the research question
- A well-characterized metabolic intervention with broad clinical interest is needed
For metabolic peptide research, Proxiva Labs also offers MOTS-c — a mitochondrial-derived peptide that activates AMPK and improves cellular energy metabolism through a peptide-based (rather than coenzyme-based) mechanism.
Frequently Asked Questions
Is Semax or NAD+ better for brain health?
They protect the brain through different mechanisms. Semax directly enhances BDNF and synaptic plasticity — the brain’s learning and repair system. NAD+ fuels mitochondrial energy production and sirtuin-mediated survival pathways — the neuron’s power supply. For cognitive enhancement, Semax has more direct evidence. For metabolic neuroprotection and age-related energy decline, NAD+ is more relevant.
Can Semax and NAD+ be used together?
They target entirely different pathways (neurotrophic signaling vs mitochondrial energy/sirtuins) with no known interactions. A combination would theoretically provide both enhanced synaptic function (Semax) and improved neuronal energy/repair capacity (NAD+), addressing two major pillars of neuroprotection simultaneously.
What is the best nootropic peptide?
Semax is the most well-studied nootropic peptide, with Russian clinical approval and direct BDNF-enhancing evidence. It is the only nootropic peptide with clinical trial data from stroke recovery studies and a regulatory approval for cognitive enhancement. Other peptides with cognitive relevance include Selank (anxiolytic/cognitive) and Dihexa (neurotrophic, highly potent).
References
- Dolotov OV, et al. Semax, an analogue of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60.
- Glazova NY, et al. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations. Neuropeptides. 2014;48(4):233-241.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471.
- Wang X, et al. Nicotinamide mononucleotide protects against ?-amyloid oligomer-induced cognitive impairment. Brain Res. 2016;1643:1-9.
About Proxiva Labs: We supply research-grade Semax for cognitive and neuroprotective research. For metabolic peptide approaches to cellular energy, see MOTS-c. Browse the complete research peptide catalog.
All products are sold strictly for research purposes only. Not for human consumption.